PRISMATIC
Dead / Abandoned — Abandoned — after inter partes decision (as of 21 Mar 2024)
What this means for you
This application is over — abandoned 21 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97762122
- Mark type
- Stylized text
- Filed
- 20 Jan 2023
- Published for opposition
- 29 Aug 2023
- Abandoned
- 21 Mar 2024
- Attorney of record
- JAMIE E STERNBERG
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer programs using artificial intelligence for machine learning; downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer software, downloadable computer software platforms, downloadable mobile applications, and downloadable software using artificial intelligence and machine learning for scientific research and development; downloadable computer programs using artificial intelligence for machine learning in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals
- Class 042 — Scientific and technological services: Scientific research consulting services in the field of science, genetics, biology, life sciences, biotechnology, drug development, and pharmaceuticals; scientific research consulting; scientific research and development; scientific services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, oncological and diabetes-related data; genetic and tumor mapping for scientific and medical purposes; providing scientific research information; drug discovery services; providing an online searchable database in the fields of genetics, oncology, and diabetes for scientific research purposes; scientific research services, namely, analyzing scientific, genetic, oncological, biological and diabetes related data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing scientific and clinical research and scientific consulting services by using machine learning and artificial intelligence technology in the fields of genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; medical and scientific research and consulting, namely, conducting and designing clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services, namely, services using computer algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer, diabetes, and other diseases; pharmaceutical drug development services; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations; consulting services in the field of pharmaceutical research and development; providing temporary use of online non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of science, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; providing a web site featuring temporary use of non-downloadable software featuring artificial intelligence and machine learning technologies for scientific research and development in the fields of science, genetics, oncology, diabetes, biology, life sciences, biotechnology, drug development, and pharmaceuticals; software design and development; computer software installation and maintenance; DNA analysis services for scientific research purposes; application service provider (ASP) featuring software using artificial intelligence for machine learning
Owner
- Zephyr AI, Inc., Dallas, TX, US
- Zephyr AI, Inc., Dallas, TX, US
Prosecution history
- 21 Mar 2024 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 21 Mar 2024 — ABANDONMENT - AFTER INTER PARTES DECISION
- 21 Mar 2024 — OPPOSITION TERMINATED NO. 999999
- 21 Mar 2024 — OPPOSITION SUSTAINED NO. 999999
- 21 Dec 2023 — OPPOSITION INSTITUTED NO. 999999
- 20 Sept 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 29 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2023 — PUBLISHED FOR OPPOSITION
- 09 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Apr 2023 — NON-FINAL ACTION E-MAILED